Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03761173 · ClinicalTrials.gov registry record
FlowTriever All-Comer Registry for Patient Safety and Hemodynamics
A clinical trial, sponsored by Inari Medical.
- Completed
- Registry status
- 1,200
- Enrollment target
NCT03761173 is a clinical trial that has completed, run by Inari Medical. The registered enrollment target is 1,200 participants.
The verdict
NCT03761173 has completed, sponsored by Inari Medical.
- COMPLETED
- Registry status
- 1,200 participants
- Enrollment target
Study Summary
To evaluate the safety and effectiveness of the FlowTriever System for use in the removal of emboli from the pulmonary arteries in the treatment of acute pulmonary embolism (PE). The use of the device will be assessed in a real-world population, with eligibility criteria that closely approximate its use in clinical practice. Up to 300 additional patients with anticoagulation treatment as the initial planned primary treatment strategy for intermediate risk PE will also be evaluated (US only).
Interventions
- DEVICE FlowTriever System
- DRUG Anticoagulation Agents
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,200 participants |
| Start Date | 2018-12-15 |
| Est. Completion | 2024-09-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03761173
The ClinicalTrials.gov registry entry for NCT03761173 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Inari Medical, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which FlowTriever System is the first listed.
NCT03761173 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03761173 about?
NCT03761173 is a clinical study titled "FlowTriever All-Comer Registry for Patient Safety and Hemodynamics". To evaluate the safety and effectiveness of the FlowTriever System for use in the removal of emboli from the pulmonary arteries in the treatment of acute pulmonary embolism (PE). The use of the device will be assessed in a real-world population, with eligibility criteria that closely approximate its...
What is the current status of trial NCT03761173?
This trial is currently completed. The enrollment target is 1,200 participants. The study started on 2018-12-15. Estimated completion is 2024-09-04.
What interventions are being tested in trial NCT03761173?
The interventions under investigation include: FlowTriever System (DEVICE), Anticoagulation Agents (DRUG).
Who is sponsoring clinical trial NCT03761173?
This trial is sponsored by Inari Medical, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.